<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21074" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Enchondroma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Biondi</surname>
            <given-names>Nicholas L.</given-names>
          </name>
          <aff>Campbell Un / Cape Fear Valley MC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tiwari</surname>
            <given-names>Vivek</given-names>
          </name>
          <aff>Apollo Sage Hospital, Bhopal, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Varacallo</surname>
            <given-names>Matthew</given-names>
          </name>
          <aff>Penn Highlands Healthcare System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nicholas Biondi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vivek Tiwari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Varacallo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21074.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Enchondromas are benign&#x000a0;hyaline cartilage tumors of unknown etiology occurring in bones of endochondral origin. These&#x000a0;lesions account for approximately 3% of bone&#x000a0;neoplasms and up to 13% of benign bone growths. Enchondromas are usually solitary, central, metaphyseal tubular bone lesions, favoring the small hand and foot bones, femur, and humerus.</p>
        <p>Enchondromatous tumor growth typically begins in childhood, arising from growth plate cartilage or chondrocytes that initially&#x000a0;proliferate&#x000a0;but fail to&#x000a0;develop&#x000a0;normally&#x000a0;and&#x000a0;persist until adulthood. The symptoms are often nonspecific, including pain, swelling, and deformity. Asymptomatic lesions typically do not require treatment. However, pathologic fractures are common. Symptomatic enchondroma lesions are managed surgically, usually by simple curettage with bone grafting.</p>
        <p>This activity for healthcare professionals is designed to enhance the learners' competence in evaluating and managing enchondromas. Valuable knowledge will be gained to enhance the learners' ability to collaborate with a multidisciplinary team caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the&#x000a0;histopathology&#x000a0;and symptomatology&#x000a0;of enchondromas.</p></list-item><list-item><p>Describe the clinical evaluation process and interpret&#x000a0;diagnostic test results in enchondroma cases.</p></list-item><list-item><p>Explain the&#x000a0;management options for enchondromas and formulate a personalized treatment plan for a patient with this condition.</p></list-item><list-item><p>Collaborate with an&#x000a0;interprofessional team&#x000a0;caring for&#x000a0;patients with enchondroma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21074">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21074.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Bone is a unique connective tissue type, being one that undergoes mineralization. Bone's inorganic component consists of calcium hydroxyapatite, which imparts strength and toughness. This mineral is also the body's main calcium (99%) and phosphate (85%) reservoir and stores 65% of its sodium and magnesium.</p>
        <p>Meanwhile, bone's organic component is comprised of bone cells and matrix proteins. The bone cells include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Osteoprogenitor cells: pluripotent mesenchymal stem cells in bone surfaces that growth factors can stimulate to differentiate into osteoblasts</p>
          </list-item>
          <list-item>
            <p>Osteoblasts: initiate mineralization and produce, transport, and arrange matrix proteins. Osteoblast actions are regulated by parathyroid hormone, vitamin D, estrogen, growth factors, cytokines, leptin, and low-density lipoprotein-related protein 5. Osteoblasts may become osteocytes or surface-lining cells of bones.</p>
          </list-item>
          <list-item>
            <p>Osteocytes: the most numerous cells in bone. Osteocytes participate in key bodily functions like calcium and phosphate homeostasis and cyclic adenosine monophosphate activation.</p>
          </list-item>
          <list-item>
            <p>Osteoclast: hematopoietic progenitor cell-derived bone cells responsible for bone resorption</p>
          </list-item>
        </list>
        <p>Bone matrix proteins include type 1 collagen and noncollagenous osteoblast-derived proteins.&#x000a0;</p>
        <p><italic toggle="yes">Homeobox genes</italic>&#x000a0;encode the skeletal morphogenesis regulators. Mesenchyme from the following regions gives rise to different parts of the skeleton:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cranial neural crest: craniofacial skeleton</p>
          </list-item>
          <list-item>
            <p>Paraxial mesoderm: axial skeleton</p>
          </list-item>
          <list-item>
            <p>Lateral plate mesoderm: appendicular skeleton</p>
          </list-item>
        </list>
        <p>In the embryo, craniofacial and clavicular bones undergo intramembranous ossification, whereby osteoblasts form bone directly from mesenchyme. These bones enlarge only when new bone deposits on the surface&#x02014;a process called "appositional growth." Meanwhile, most other bones begin as a cartilage anlage, undergoing enchondral ossification around the 8th week of gestation. Bones that form this way increase in length due to the development of the physis or growth plate at their ends. Growth plates have a cartilaginous core covered by a layer of bone (primary spongiosa). Enchondral ossification within growth plates increases bone length and diameter.&#x000a0;</p>
        <p>Hyaline-cartilage bone tumors arise either within the medullary cavity or on the bone surface. Enchondromas are benign medullary cavity hyaline-cartilage tumors occurring in bones of endochondral origin.<xref ref-type="bibr" rid="article-21074.r1">[1]</xref>&#x000a0;These growths are usually solitary, central, metaphyseal tubular bone lesions. In contrast, subperiosteal or juxtacortical chondromas form on the bone surface.</p>
        <p>Enchondromas arise most commonly from the hand and foot bones but may occasionally appear in the femur and humerus. These neoplasms are also the most common primary bone tumors of the hand, where they commonly appear in the proximal phalanges. Other common sites include the middle phalanges, metacarpals, and distal phalanges.<xref ref-type="bibr" rid="article-21074.r2">[2]</xref><xref ref-type="bibr" rid="article-21074.r3">[3]</xref></p>
        <p>Enchondromatous tumors typically begin and grow in childhood, arising from rests of growth plate cartilage or chondrocytes that initially proliferate but stop developing normally and persist throughout adulthood.<xref ref-type="bibr" rid="article-21074.r4">[4]</xref>&#x000a0;These tumors are most frequently noted in the 3rd and 4th decades of life. The small finger is the most commonly affected digit.<xref ref-type="bibr" rid="article-21074.r5">[5]</xref>&#x000a0;Hand enchondromas are unique, as they may also demonstrate cellular atypia, resembling chondrosarcoma on histopathological examination.<xref ref-type="bibr" rid="article-21074.r6">[6]</xref></p>
        <p>Enchondromas have malignant potential and may transform into chondrosarcoma.<xref ref-type="bibr" rid="article-21074.r7">[7]</xref>&#x000a0;However, malignancies arising from enchondromas are low-grade and rarely metastasize to other body regions.</p>
      </sec>
      <sec id="article-21074.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The persistence of growth plate chondrocytes in bone leads to&#x000a0;enchondroma formation.<xref ref-type="bibr" rid="article-21074.r8">[8]</xref>&#x000a0;However, the reason for chondrocyte persistence is unknown. Genetic mutations are rare and often sporadic if involved.</p>
        <p>Somatic isocitrate dehydrogenase-1 (<italic toggle="yes">IDH1</italic>) and 2 (<italic toggle="yes">IDH2</italic>) gene mutations have been implicated. Such mutations lead to the synthesis of defective isocitrate dehydrogenase&#x02014;a tricarboxylic acid cycle enzyme that catalyzes isocitrate conversion to &#x003b1;-ketoglutarate.<xref ref-type="bibr" rid="article-21074.r9">[9]</xref><xref ref-type="bibr" rid="article-21074.r10">[10]</xref>&#x000a0;The mutated enzyme&#x000a0;catalyzes&#x000a0;&#x003b1;-ketoglutarate reduction to the&#x000a0;oncometabolite D-2-hydroxyglutarate (D-2-HG). D-2-HG&#x000a0;competitively inhibits &#x003b1;-ketoglutarate-dependent enzymes, leading to&#x000a0;DNA hypermethylation and histone modification.<xref ref-type="bibr" rid="article-21074.r11">[11]</xref> These processes&#x000a0;promote cartilaginous tumor formation and prevent normal osteogenic differentiation of mesenchymal stem cells.<xref ref-type="bibr" rid="article-21074.r12">[12]</xref></p>
        <p>Somatic parathyroid hormone 1 receptor (<italic toggle="yes">PTHR1</italic>)&#x000a0;gene mutations&#x000a0;have also been found&#x000a0;in enchondromas.&#x000a0;The parathyroid hormone 1 receptor signaling pathway is a key regulator of enchondral ossification.&#x000a0;Additionally, the Indian Hedgehog pathway is constitutively active in some cases of enchondromas. Wnt/&#x003b2;-catenin signaling&#x000a0;downregulates&#x000a0;Indian Hedgehog activity in enchondromas. Thus, the Wnt/&#x003b2;-catenin signaling pathway is a potential therapeutic target in treating enchondromas.<xref ref-type="bibr" rid="article-21074.r13">[13]</xref></p>
      </sec>
      <sec id="article-21074.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Enchondromas are the most prevalent intraosseous cartilage neoplasms, accounting for approximately 3% of bone tumors and 13% of benign bone growths. Most appear in the small hand and foot bones, but femoral and humeral enchondromas have also been documented.<xref ref-type="bibr" rid="article-21074.r14">[14]</xref></p>
        <p>Enchondromatosis is the growth of multiple enchondromas. Ollier disease is a condition arising from enchondromatosis with an asymmetric distribution in the appendicular skeleton. This bone disorder has an estimated prevalence of 1 in 100,000.<xref ref-type="bibr" rid="article-21074.r15">[15]</xref></p>
        <p>Maffucci syndrome is a condition presenting with enchondromatosis and multiple soft tissue hemangiomas and lymphangiomas. This disorder is rare, with fewer than 200 cases reported in the literature.<xref ref-type="bibr" rid="article-21074.r16">[16]</xref>&#x000a0;Although histologically similar to a solitary enchondroma, the cytological changes in this syndrome appear more bizarre.</p>
        <p>Both Ollier disease and Maffucci syndrome are associated with an increased risk of chondrosarcoma and visceral malignancies.</p>
      </sec>
      <sec id="article-21074.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Terminal chondrocyte differentiation in the growth plate is dysregulated in enchondroma formation. Most enchondromas begin in the medullary portion of the diaphysis. The tumors arise from ectopic cartilaginous nests in the metaphyseal region and expand outward toward the cortex.&#x000a0;Enlarging lesions may cause a pathologic fracture.<xref ref-type="bibr" rid="article-21074.r17">[17]</xref>&#x000a0;</p>
        <p>The enchondromatous tumors of Ollier disease are typically located&#x000a0;at the epiphysis, metaphysis, and diaphysis, potentially hindering normal bone growth. Limb shortening may occur due to&#x000a0;epiphyseal invasion, metaphyseal widening, and long-bone bowing.<xref ref-type="bibr" rid="article-21074.r18">[18]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-21074.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>On gross examination, the typical enchondroma is smaller than 3 centimeters. Microscopically, enchondromas appear as gray-blue, translucent, hypocellular, avascular tumors with abundant hyaline cartilage. The nuclei of these cells are fairly regular, with few mitotic figures. Juxtacortical chondromas and enchondromas in regions like the hands may be hypercellular and atypical but remain benign.<xref ref-type="bibr" rid="article-21074.r19">[19]</xref></p>
        <p>Chondroid matrix punctate calcifications define the microscopic appearance of enchondromas. The tumor is composed of well-circumscribed, benign hyaline cartilage nodules. Limited engulfment of the adjacent lamellar and cortical bone is seen. Chondrocyte nuclei are small and uniformly round with condensed chromatin. Binucleate forms&#x000a0;are rare. Endochondral ossification foci may be found in heavily calcified enchondromas.</p>
        <p>Long bone enchondromas often appear benign microscopically but can recur after removal. As with many tumors, staging systems are used to classify the tumor further. Bone sarcoma staging follows the tumor, node, and metastasis (TNM) guidelines.<xref ref-type="bibr" rid="article-21074.r20">[20]</xref></p>
        <p>The enchondromas in syndromes like Ollier disease and Maffucci syndrome exhibit more cellularity and atypia than the classic, single enchondroma.<xref ref-type="bibr" rid="article-21074.r21">[21]</xref>&#x000a0;The increased cellularity and atypia make distinguishing enchondromatosis tumors from chondrosarcoma more difficult, especially when the malignancy is in its early stages. Benign, atypical cartilaginous lesions and chondrosarcoma grade 1 are nearly indistinguishable. However, cartilaginous lesions are typically hypocellular, while chondrosarcoma grade 1 has a hypercellular appearance. Additionally, chondrosarcoma exhibits more binucleated chondrocytes, pleomorphism, cortical destruction, host bone engulfment, and irregular cellular distribution.</p>
      </sec>
      <sec id="article-21074.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Enchondromas may&#x000a0;manifest at any age. However, the onset of presentation of the solitary enchondroma is classically in the 2nd or 3rd decade of life. Enchondromatosis syndromes become symptomatic&#x000a0;earlier, typically before age 10.<xref ref-type="bibr" rid="article-21074.r22">[22]</xref>&#x000a0;The tumor&#x000a0;is often&#x000a0;discovered after the patient develops a pathologic fracture.&#x000a0;Pain, swelling, and deformity are common. Pathologic fractures are seen in&#x000a0;40-60% of patients at presentation.<xref ref-type="bibr" rid="article-21074.r23">[23]</xref>&#x000a0;Others are detected&#x000a0;incidentally on radiographic imaging.<xref ref-type="bibr" rid="article-21074.r24">[24]</xref>&#x000a0;</p>
        <p>The classic location of the lesions is in the proximal metaphyses of proximal phalanges, with a predilection for the ulnar side of the bones.<xref ref-type="bibr" rid="article-21074.r25">[25]</xref>&#x000a0;Distal phalangeal enchondromas may have associated nail deformities.</p>
        <p>A thorough examination of the hand and wrist is necessary for patients with hand enchondromas. Passive movements of the interphalangeal and metacarpophalangeal joints need to be evaluated. Flexor and extensor tendon&#x000a0;function must also be assessed, as distal phalangeal tumors can cause flexor tendon avulsion.</p>
        <p>The skin, chest, abdomen, and neuromuscular function must be&#x000a0;fully evaluated in patients with suspected enchondromatosis syndromes. These individuals are at risk of developing multiple hemangiomas and ovarian and brain malignancies.</p>
      </sec>
      <sec id="article-21074.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Plain&#x000a0;hand radiographs with posteroanterior, lateral, and oblique views should be&#x000a0;obtained during the initial evaluation&#x000a0;of&#x000a0;hand enchondromas (see <bold>Image</bold>. Enchondroma Radiography). These tumors&#x000a0;have varied radiographic appearances, influenced by location and extent of calcification.&#x000a0;Enchondromas typically appear as well-defined, solitary metaphyseal defects, especially in the long bones. Centrally located lesions usually appear as well-circumscribed areas of rarefaction, most frequently diaphyseal, with an expanded surrounding cortex. Juxtacortical lesions are eccentric. located beneath the periosteum in well-defined cortical defects. Small, flocculent foci of calcification are visible within the tumors. Some may resemble medullary bone infarcts.<xref ref-type="bibr" rid="article-21074.r26">[26]</xref></p>
        <p>Radiographically visible calcifications usually appear as fine, punctate stipplings. A bone infarct may be present if these&#x000a0;areas are more pronounced.&#x000a0;Some calcifications&#x000a0;appear as&#x000a0;rings. Larger lesions can cause endosteal scalloping&#x000a0;and cortical expansion and thinning. Heavily calcified lesions may resemble bone infarction or bone islands, while an unclassified lesion may appear lytic. Cortical thinning or breach, tumor expansion,&#x000a0;and&#x000a0;soft tissue involvement&#x000a0;are associated with advanced lesions or chondrosarcoma.<xref ref-type="bibr" rid="article-21074.r27">[27]</xref></p>
        <p>Computed tomography (CT) is useful&#x000a0;in evaluating&#x000a0;matrix mineralization and cortex integrity.&#x000a0;Magnetic resonance imaging (MRI)&#x000a0;helps identify aggressive and destructive features. Enchondroma and chondrosarcoma often appear similarly on first-pass analysis. Both exhibit low signal intensities on T1&#x000a0;and reciprocal high-intensity changes&#x000a0;with a lobular growth pattern on T2-weighted imaging. Both show enhancement with gadolinium contrast in peripheral and spatial areas.</p>
        <p>Neither dynamic contrast-enhanced MRI nor advanced techniques&#x000a0;like diffusion-weighted imaging and hydrogen proton spectroscopy have proven effective in differentiating enchondroma from chondrosarcoma. However,&#x000a0;peritumoral edema&#x000a0;may differentiate these tumors.&#x000a0;A&#x000a0;case series analysis revealed that chondrosarcoma&#x000a0;is more likely to have&#x000a0;peritumoral edema than enchondroma.&#x000a0;Both CT and MRI can easily distinguish bone infarct from enchondroma.</p>
        <p>Evidence of a lesion in a radiologic study is often insufficient&#x000a0;to diagnose an enchondroma. Diagnostic confirmation requires histopathologic examination of the biopsied&#x000a0;lesion. However, differentiating between benign and malignant hyaline cartilage lesions&#x000a0;poses an even greater challenge. In some cases, the diagnosis may remain in question despite extensive tissue examination&#x000a0;unless the suspicion of enchondroma or early chondrosarcoma is strong. Indicators of potential malignancy include the following:<xref ref-type="bibr" rid="article-21074.r28">[28]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Large size</p>
          </list-item>
          <list-item>
            <p>Presence of a large unmineralized component</p>
          </list-item>
          <list-item>
            <p>Significant thinning of the adjacent cortex</p>
          </list-item>
          <list-item>
            <p>Bone scan activity greater than that of the anterior superior iliac spine</p>
          </list-item>
          <list-item>
            <p>Progressive chondrite matrix destruction&#x000a0;due to an expanding non-mineralized component</p>
          </list-item>
          <list-item>
            <p>Rapidly&#x000a0;enlarging, painful lesion</p>
          </list-item>
          <list-item>
            <p>Expansile soft tissue mass</p>
          </list-item>
        </list>
        <p>Only&#x000a0;2 known biomarkers can distinguish enchondroma from chondrosarcoma: periostin and &#x003b1;-methylacyl-CoA racemase (AMACR).&#x000a0;Periostin, a stroma-related protein, is reportedly absent in enchondroma but present in low-grade chondrosarcoma.<xref ref-type="bibr" rid="article-21074.r29">[29]</xref>&#x000a0;Meanwhile, AMACR,&#x000a0;a mitochondrial and peroxisomal enzyme,&#x000a0;is often expressed by enchondroma but rarely by chondrosarcoma.<xref ref-type="bibr" rid="article-21074.r30">[30]</xref>&#x000a0;Further investigation is needed to validate&#x000a0;the reliability of these biomarkers in enchondroma and chondrosarcoma diagnosis.</p>
      </sec>
      <sec id="article-21074.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Currently, no standardized algorithm for enchondroma surgery exists. Asymptomatic enchondromas&#x000a0;may be observed, though routine radiographic follow-up for asymptomatic lesions is usually unnecessary. Symptomatic lesions and tumors producing pathologic fractures often improve with surgery. Operative management also helps establish a definitive diagnosis. However, the optimal timing of surgical intervention is unknown. Early and delayed surgical intervention was shown to have similar functional outcomes.</p>
        <p>The surgical technique typically used for treating symptomatic enchondroma is simple curettage with bone grafting. The bone graft may be allogeneic, autogenous, or synthetic. The graft type's impact on healing, recurrence, complications, and malignant transformation is unknown. The necessity of curettage with grafting remains unproven.</p>
        <p>Care must be taken to prevent tumor dissemination during surgery. Tourniquet control without exsanguination using an esmarch bandage is performed during the procedure. Adjuncts used to kill the residual tumor cells and help reduce recurrence include phenol, liquid nitrogen, cryotherapy, polymethyl methacrylate, and electrocautery.<xref ref-type="bibr" rid="article-21074.r31">[31]</xref><xref ref-type="bibr" rid="article-21074.r32">[32]</xref>&#x000a0;However, no data suggests which adjunct is superior among the various treatment options. A frozen section is not recommended in these procedures.</p>
        <p>The bone void can be filled using an autograft, allograft, bone substitute, or bone cement after curettage. However, some studies have demonstrated that leaving the void unfilled renders equivalent functional outcomes. This technique saves surgical time, prevents donor site morbidity, and minimizes foreign body-induced complications, as when allografts and bone cement are used.</p>
        <p>Fracture prophylaxis by internal fixation methods is controversial. Previous guidelines based on retrospective studies were limited by the use of plain radiographs, subjective patient information, and inadequate understanding of the biomechanical factors involved in the neoplastic process. The Mirels criteria were developed to quantify bone neoplasm-related fracture risk. These criteria consider the location, pain, and lesion type and size.<xref ref-type="bibr" rid="article-21074.r33">[33]</xref>&#x000a0;Scores greater than 8 indicate a significant fracture risk. Thus, prophylactic internal fixation may be recommended in such cases. Lesions with scores less than 7 have a reduced fracture risk and may simply be observed.</p>
        <p>A 23-year retrospective review of enchondroma patients reported that enchondroma treatment with biopsy, curettage, and allograft implantation resulted in a full range of motion in more than 80% of the patients. Additionally, recurrence was rarely seen and was more common with Ollier's disease and giant-form lesions. Preoperative pathologic fractures are associated with a greater risk of postoperative extension deficit.</p>
        <p>Various surgical techniques have been used for enchondroma treatment. One case report described a successful endoscopic curettage and bone grafting of a proximal finger phalangeal enchondroma.<xref ref-type="bibr" rid="article-21074.r34">[34]</xref>&#x000a0;Another case series reported bone fixation with headless intramedullary screws after long-hand bone enchondroma resection with good results.<xref ref-type="bibr" rid="article-21074.r35">[35]</xref>&#x000a0;A 10-year retrospective cohort study found that osteoscopic surgery&#x000a0;leads to earlier functional recovery and fewer complications than open surgery.<xref ref-type="bibr" rid="article-21074.r36">[36]</xref>&#x000a0;Radiofrequency ablation was recently shown to have value in treating flat pelvic bone enchondromas.<xref ref-type="bibr" rid="article-21074.r37">[37]</xref></p>
      </sec>
      <sec id="article-21074.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Conditions that may present similarly to enchondromatous lesions include the following:<xref ref-type="bibr" rid="article-21074.r38">[38]</xref><xref ref-type="bibr" rid="article-21074.r39">[39]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Bone infarction, which has a similar&#x000a0;radiographic appearance</p>
          </list-item>
          <list-item>
            <p>Tuberculous dactylitis, due to bone pain in the absence of a fracture</p>
          </list-item>
          <list-item>
            <p>Low-grade chondrosarcoma, also due to non-fracture-related bone pain</p>
          </list-item>
          <list-item>
            <p>Other&#x000a0;benign neoplasms&#x000a0;like giant cell reparative granuloma, giant cell tumors, and chondroblastoma</p>
          </list-item>
        </list>
        <p>These conditions may be differentiated from enchondromas with a good clinical evaluation, appropriate laboratory&#x000a0;and imaging studies, and histopathology.</p>
      </sec>
      <sec id="article-21074.s11" sec-type="Staging">
        <title>Staging</title>
        <p>Takigawa proposed a radiographic classification for enchondromas, which had 5 morphological categories:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type A: central</p>
          </list-item>
          <list-item>
            <p>Type B: eccentric</p>
          </list-item>
          <list-item>
            <p>Type C: associated</p>
          </list-item>
          <list-item>
            <p>Type D: polycentric</p>
          </list-item>
          <list-item>
            <p>Type E: giant form</p>
          </list-item>
        </list>
        <p>One study found that the Takigawa classification could predict the optimal enchondroma treatment option.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.3390/app12031300">[44]</ext-link>&#x000a0;However, more large-scale studies are necessary to evaluate the reliability of this system in predicting prognosis and surgical outcomes of enchondromatous growths.</p>
      </sec>
      <sec id="article-21074.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Solitary enchondromatous lesions are typically self-limited. Recurrence is rare following curettage and bone grafting.&#x000a0;However, giant-form tumors and&#x000a0;long bone involvement&#x000a0;are associated with a&#x000a0;higher recurrence risk.&#x000a0;Meanwhile, enchondromatosis increases not only the risk of recurrence but also the probability of malignant transformation.&#x000a0;</p>
      </sec>
      <sec id="article-21074.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The potential complications of delayed enchondroma treatment include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intramedullary enchondroma growth and cortical bone encroachment may produce a pathologic fracture.</p>
          </list-item>
          <list-item>
            <p>Enchondromas may interfere with proper bone development in children.</p>
          </list-item>
          <list-item>
            <p>Pathologic fractures&#x000a0;requiring primary surgery&#x000a0;increase hospitalization costs.</p>
          </list-item>
          <list-item>
            <p>Delayed surgery of pathological fractures, ie,&#x000a0;when surgical intervention is postponed until bone union is achieved,&#x000a0;may lead to&#x000a0;prolonged immobilization. The time to return to work may be longer.</p>
          </list-item>
          <list-item>
            <p>Stiffness, joint deformities, and contractures&#x000a0;may be seen following surgeries, especially in the hands.</p>
          </list-item>
          <list-item>
            <p>Malignant transformation to chondrosarcoma may occur following skeletal maturity. However, transformation of a&#x000a0;solitary enchondromatous lesion is rare (less than 1%).<xref ref-type="bibr" rid="article-21074.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Malignant transformation risk is increased in Ollier disease and Maffucci syndrome.<xref ref-type="bibr" rid="article-21074.r41">[41]</xref><xref ref-type="bibr" rid="article-21074.r42">[42]</xref>&#x000a0;These two&#x000a0;conditions are also associated with non-sarcomatous,&#x000a0;extraosseous neoplasms, including brain tumors.<xref ref-type="bibr" rid="article-21074.r43">[43]</xref></p>
          </list-item>
        </list>
        <p>Prompt consultation with an orthopedic specialist regarding this condition helps minimize complications.</p>
      </sec>
      <sec id="article-21074.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Enchondroma-specific prevention measures are unavailable, as the cause&#x000a0;of this condition&#x000a0;is poorly understood. Genetic mutations are sporadic if present, so a clear inheritance pattern has not been elucidated. However, patients may be counseled about making healthy lifestyle choices to maintain bone health. Such measures include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Maintaining a healthy diet, particularly one incorporating rich calcium and vitamin D sources</p>
          </list-item>
          <list-item>
            <p>Having regular primary care visits, especially if the individual has a family history of bone disease</p>
          </list-item>
          <list-item>
            <p>Avoiding habits&#x000a0;that may harm bone health, such as smoking and drinking</p>
          </list-item>
          <list-item>
            <p>Practicing safety in sports and recreation to prevent injuries</p>
          </list-item>
        </list>
        <p>Patients must be reminded to seek prompt medical attention if they experience persistent musculoskeletal&#x000a0;symptoms.</p>
      </sec>
      <sec id="article-21074.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The most important points to remember about enchondroma management are the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Enchondroma is a benign hyaline cartilage tumor arising within a long bone's medullary cavity.</p>
          </list-item>
          <list-item>
            <p>Most enchondromatous lesions are solitary. Enchondromatosis is the occurrence of multiple enchondromas.</p>
          </list-item>
          <list-item>
            <p>The cause of the condition is unknown. Genetic mutations, if present, are sporadic.</p>
          </list-item>
          <list-item>
            <p>These lesions usually develop in small hand and foot bones, though they may also grow in the femur and humerus.</p>
          </list-item>
          <list-item>
            <p>Enchondromas increase the risk of pathologic fractures.</p>
          </list-item>
          <list-item>
            <p>These lesions may disrupt normal bone development in children.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Enchondromas are often asymptomatic and discovered accidentally on imaging for another condition or if a pathologic fracture develops.</p>
          </list-item>
          <list-item>
            <p>Solitary lesions have a small chance of malignant transformation.</p>
          </list-item>
          <list-item>
            <p>Enchondromatosis, as in cases of Ollier disease and Maffucci syndrome, is associated with an increased risk of chondrosarcoma and visceral malignancies.</p>
          </list-item>
          <list-item>
            <p>Definitive diagnosis often involves a histological examination of the tissue, typically obtained through a biopsy or surgical tumor removal.</p>
          </list-item>
          <list-item>
            <p>Enchondromas typically appear as well-defined, radiolucent areas with small, stippled calcifications on x-rays. Other imaging modalities like CT and MRI may help determine other important tumor characteristics, like bone infarcts and aggressive features.</p>
          </list-item>
          <list-item>
            <p>Asymptomatic enchondromas do not require immediate treatment.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Surgery may be considered in individuals with persistent symptoms or increased fracture risk and if concerns about malignant transformation are great.</p>
          </list-item>
        </list>
        <p>Specific preventive measures for this condition are unavailable. However, prompt surgical intervention is beneficial for patients at risk for pathologic fractures or who have developed one.</p>
      </sec>
      <sec id="article-21074.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Enchondromas are best managed with an interprofessional approach. The members of the multidisciplinary team should include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary care physicians: responsible for initial patient evaluation, referrals, and care coordination</p>
          </list-item>
          <list-item>
            <p>Radiologists: interpret imaging studies to assess the tumor's characteristics in aid of management</p>
          </list-item>
          <list-item>
            <p>Orthopedic surgeons: share their expertise in evaluating and treating individuals with suspected enchondroma. Orthopedic surgeons determine the need for surgical intervention and perform a biopsy or tumor excision if required.</p>
          </list-item>
          <list-item>
            <p>Pain management specialists: provide effective pain management to individuals experiencing pain associated with enchondromas. These professionals also provide anesthesia care if surgery is performed.</p>
          </list-item>
          <list-item>
            <p>Pathologists: analyze tissue samples obtained through biopsy or surgical excision to confirm the diagnosis and rule out malignancy</p>
          </list-item>
          <list-item>
            <p>Oncologists: share their expertise if concerns about malignant transformation are great or if a diagnosis of chondrosarcoma is confirmed. Oncologists also collaborate with orthopedic surgeons to develop a definitive treatment plan.</p>
          </list-item>
          <list-item>
            <p>Physical therapists: help with rehabilitation after surgical intervention, especially if joints are involved, or patients develop functional limitations</p>
          </list-item>
          <list-item>
            <p>Genetic counselors: may provide information about the genetic aspects of the condition and potential implications for family members</p>
          </list-item>
          <list-item>
            <p>Rehabilitation specialists: collaborate with physical therapists to optimize rehabilitation strategies. These professionals may also recommend assistive devices if necessary.</p>
          </list-item>
        </list>
        <p>Effective communication and collaboration among these professionals are essential for providing holistic care, making accurate diagnoses, and tailoring treatment plans for individuals with enchondroma.</p>
      </sec>
      <sec id="article-21074.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21074">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/joint-muscle-and-bone/enchondroma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21074">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21074/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21074">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21074.s18">
        <fig id="article-21074.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Enchondroma Radiography. This posteroanterior x-ray shows rarefaction mostly in the diaphysis and proximal metaphysis of the right 3rd proximal phalanx. Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="enchondroma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21074.s19">
        <title>References</title>
        <ref id="article-21074.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suster</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Differential Diagnosis of Cartilaginous Lesions of Bone.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>144</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-82</page-range>
            <pub-id pub-id-type="pmid">31877083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simon</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pogoda</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>H&#x000f6;velborn</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zustin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Amling</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barvencik</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Incidence, histopathologic analysis and distribution of tumours of the hand.</article-title>
            <source>BMC Musculoskelet Disord</source>
            <year>2014</year>
            <month>May</month>
            <day>28</day>
            <volume>15</volume>
            <fpage>182</fpage>
            <pub-id pub-id-type="pmid">24885007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sassoon</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Fitz-Gibbon</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Harmsen</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Enchondromas of the hand: factors affecting recurrence, healing, motion, and malignant transformation.</article-title>
            <source>J Hand Surg Am</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>1229</fpage>
            <page-range>1229-34</page-range>
            <pub-id pub-id-type="pmid">22542061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerr</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Cipriani</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Benign Cartilage-forming Tumors.</article-title>
            <source>Surg Pathol Clin</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>585</fpage>
            <page-range>585-603</page-range>
            <pub-id pub-id-type="pmid">34742482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wessel</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Christ</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Athanasian</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Impact of Patient and Tumor Characteristics on Range of Motion and Recurrence Following Treatment of Enchondromas of the Hand.</article-title>
            <source>J Hand Surg Am</source>
            <year>2023</year>
            <month>May</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>512.e1</fpage>
            <page-range>512.e1-512.e7</page-range>
            <pub-id pub-id-type="pmid">35115192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lubahn</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Bachoura</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Enchondroma of the Hand: Evaluation and Management.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>625</fpage>
            <page-range>625-33</page-range>
            <pub-id pub-id-type="pmid">27454024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulligan</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>How to Diagnose Enchondroma, Bone Infarct, and Chondrosarcoma.</article-title>
            <source>Curr Probl Diagn Radiol</source>
            <year>2019</year>
            <season>May-Jun</season>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>262</fpage>
            <page-range>262-273</page-range>
            <pub-id pub-id-type="pmid">29724496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alman</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Enchondromatosis and Growth Plate Development.</article-title>
            <source>Curr Osteoporos Rep</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-49</page-range>
            <pub-id pub-id-type="pmid">33306166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pansuriya</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>van Eijk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>d'Adamo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van Ruler</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kuijjer</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Oosting</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cleton-Jansen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>van Oosterwijk</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Verbeke</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>van Wezel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nord</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Sangiorgi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Toker</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Liegl-Atzwanger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>San-Julian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sciot</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Limaye</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kindblom</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Daugaard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Godfraind</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boon</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Vikkula</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kurek</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Szuhai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Bov&#x000e9;e</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.</article-title>
            <source>Nat Genet</source>
            <year>2011</year>
            <month>Nov</month>
            <day>06</day>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>1256</fpage>
            <page-range>1256-61</page-range>
            <pub-id pub-id-type="pmid">22057234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amary</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Damato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Halai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Eskandarpour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berisha</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bonar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fantin</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Straley</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aston</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Gale</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Tirabosco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Futreal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Presneau</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Flanagan</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.</article-title>
            <source>Nat Genet</source>
            <year>2011</year>
            <month>Nov</month>
            <day>06</day>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>1262</fpage>
            <page-range>1262-5</page-range>
            <pub-id pub-id-type="pmid">22057236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>LX</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Frye</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>QY</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Xiong</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of &#x003b1;-ketoglutarate-dependent dioxygenases.</article-title>
            <source>Cancer Cell</source>
            <year>2011</year>
            <month>Jan</month>
            <day>18</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-30</page-range>
            <pub-id pub-id-type="pmid">21251613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suijker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baelde</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Roelofs</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cleton-Jansen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bov&#x000e9;e</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.</article-title>
            <source>Oncotarget</source>
            <year>2015</year>
            <month>Jun</month>
            <day>20</day>
            <volume>6</volume>
            <issue>17</issue>
            <fpage>14832</fpage>
            <page-range>14832-42</page-range>
            <pub-id pub-id-type="pmid">26046462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deng</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Che</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/&#x003b2;-Catenin.</article-title>
            <source>Elife</source>
            <year>2019</year>
            <month>Sep</month>
            <day>04</day>
            <volume>8</volume>
            <pub-id pub-id-type="pmid">31482846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satti</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Yennapu</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Inturi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Surada</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A Rare Occurrence of Enchondroma in the Head of Femur in an Adult Male: A Case Report.</article-title>
            <source>J Orthop Case Rep</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>62</fpage>
            <page-range>62-65</page-range>
            <pub-id pub-id-type="pmid">37193382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ding</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Xiong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Skull Base Chondrosarcoma Caused by Ollier Disease: A Case Report and Literature Review.</article-title>
            <source>World Neurosurg</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>127</volume>
            <fpage>103</fpage>
            <page-range>103-108</page-range>
            <pub-id pub-id-type="pmid">30872199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prokopchuk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Andres</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Holzapfel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Friess</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Maffucci syndrome and neoplasms: a case report and review of the literature.</article-title>
            <source>BMC Res Notes</source>
            <year>2016</year>
            <month>Feb</month>
            <day>27</day>
            <volume>9</volume>
            <fpage>126</fpage>
            <pub-id pub-id-type="pmid">26920730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hakim</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Pelly</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kulendran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caris</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Benign tumours of the bone: A review.</article-title>
            <source>J Bone Oncol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>37</fpage>
            <page-range>37-41</page-range>
            <pub-id pub-id-type="pmid">26579486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silve</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>J&#x000fc;ppner</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Ollier disease.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2006</year>
            <month>Sep</month>
            <day>22</day>
            <volume>1</volume>
            <fpage>37</fpage>
            <pub-id pub-id-type="pmid">16995932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mittermayer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dominkus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krepler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schwameis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sluga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grampp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kotz</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Chondrosarcoma of the hand: is a wide surgical resection necessary?</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2004</year>
            <month>Jul</month>
            <issue>424</issue>
            <fpage>211</fpage>
            <page-range>211-5</page-range>
            <pub-id pub-id-type="pmid">15241167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kazmer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Colman</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Gitelis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Batus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blank</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>What is the clinical impact of staging and surveillance PET-CT scan findings in patients with bone and soft tissue sarcoma?</article-title>
            <source>J Surg Oncol</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>125</volume>
            <issue>5</issue>
            <fpage>901</fpage>
            <page-range>901-906</page-range>
            <pub-id pub-id-type="pmid">35023167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karaytu&#x0011f;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alpan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bayram</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Valiyev</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bilgi&#x000e7;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>&#x000d6;zger</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Long-term results of different surgical options in the management of solitary enchondroma.</article-title>
            <source>ANZ J Surg</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>92</volume>
            <issue>7-8</issue>
            <fpage>1809</fpage>
            <page-range>1809-1813</page-range>
            <pub-id pub-id-type="pmid">35621280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bierry</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Torriani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bredella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Enchondromas in children: imaging appearance with pathological correlation.</article-title>
            <source>Skeletal Radiol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>1223</fpage>
            <page-range>1223-9</page-range>
            <pub-id pub-id-type="pmid">22366808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bachoura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Lubahn</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Lubahn</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>The surgical management of hand enchondroma without postcurettage void augmentation: authors' experience and a systematic review.</article-title>
            <source>Hand (N Y)</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>461</fpage>
            <page-range>461-71</page-range>
            <pub-id pub-id-type="pmid">26330779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yildiz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Erler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Atesalp</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Basbozkurt</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Benign bone tumors in children.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-67</page-range>
            <pub-id pub-id-type="pmid">12544273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Keshav</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The management and surgical intervention timing of enchondromas: A 10-year experience.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>96</volume>
            <issue>16</issue>
            <fpage>e6678</fpage>
            <pub-id pub-id-type="pmid">28422880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gurnani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Selvin</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A Solitary Enchondroma of the Great Toe in an Adolescent Male: A Case Report.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>e21772</fpage>
            <pub-id pub-id-type="pmid">35251842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takigawa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Chondroma of the bones of the hand. A review of 110 cases.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1971</year>
            <month>Dec</month>
            <volume>53</volume>
            <issue>8</issue>
            <fpage>1591</fpage>
            <page-range>1591-600</page-range>
            <pub-id pub-id-type="pmid">5121800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davies</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Azzopardi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Botchu</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Enchondromas of the Proximal Femur in Adults as an Incidental Finding on MRI of the Pelvis.</article-title>
            <source>Indian J Radiol Imaging</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>582</fpage>
            <page-range>582-585</page-range>
            <pub-id pub-id-type="pmid">34790301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sullivan</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Kazley</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Murtaza</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cooley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>DiCaprio</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Team Approach: Evaluation and Management of Low-Grade Cartilaginous Lesions.</article-title>
            <source>JBJS Rev</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>e0054</fpage>
            <pub-id pub-id-type="pmid">32105237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers of chondrosarcoma.</article-title>
            <source>J Clin Pathol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>71</volume>
            <issue>7</issue>
            <fpage>579</fpage>
            <page-range>579-583</page-range>
            <pub-id pub-id-type="pmid">29593061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Georgiannos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lampridis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bisbinas</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Phenolization and coralline hydroxyapatite grafting following meticulous curettage for the treatment of enchondroma of the hand. A case series of 82 patients with 5-year follow-up.</article-title>
            <source>Hand (N Y)</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-5</page-range>
            <pub-id pub-id-type="pmid">25767429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bickels</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wittig</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kollender</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kellar-Graney</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Meller</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Malawer</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Enchondromas of the hand: treatment with curettage and cemented internal fixation.</article-title>
            <source>J Hand Surg Am</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>870</fpage>
            <page-range>870-5</page-range>
            <pub-id pub-id-type="pmid">12239678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howard</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Shepherd</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Cribb</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cool</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The validity of the Mirels score for predicting impending pathological fractures of the lower limb.</article-title>
            <source>Bone Joint J</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>100-B</volume>
            <issue>8</issue>
            <fpage>1100</fpage>
            <page-range>1100-1105</page-range>
            <pub-id pub-id-type="pmid">30062934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic Curettage and Bone Grafting of Enchondroma of Proximal Phalanx of Finger.</article-title>
            <source>Arthrosc Tech</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>8</issue>
            <fpage>e1335</fpage>
            <page-range>e1335-e1340</page-range>
            <pub-id pub-id-type="pmid">37654891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaempf de Oliveira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brunelli</surname>
                <given-names>JPF</given-names>
              </name>
              <name>
                <surname>Ara&#x000fa;jo Filho</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aita</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Intramedullary Fixation with Cannulated Screw After Resection of Enchondroma in the Hand: Technique Description and Case Series.</article-title>
            <source>J Hand Surg Glob Online</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>413</fpage>
            <page-range>413-420</page-range>
            <pub-id pub-id-type="pmid">37521559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Futani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawaguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sawai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tachibana</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Osteoscopic versus open surgery for the treatment of enchondroma in the foot.</article-title>
            <source>Arch Orthop Trauma Surg</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>143</volume>
            <issue>8</issue>
            <fpage>4899</fpage>
            <page-range>4899-4905</page-range>
            <pub-id pub-id-type="pmid">36813947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yiannakas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ioannides</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pantzara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Michaelides</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Radiofrequency ablation for the treatment of a presumed enchondroma in the flat bones of the pelvis.</article-title>
            <source>Skeletal Radiol</source>
            <year>2023</year>
            <month>May</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>1057</fpage>
            <page-range>1057-1061</page-range>
            <pub-id pub-id-type="pmid">36773084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baeza-Trinidad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Oteo Revuelta</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Images in clinical medicine. Spina ventosa.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>26</day>
            <volume>372</volume>
            <issue>13</issue>
            <fpage>e18</fpage>
            <pub-id pub-id-type="pmid">25806937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoshida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iwamoto</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Alternative surgical treatment for giant-cell reparative granuloma in the metacarpal, using phenol and ethanol adjuvant therapy.</article-title>
            <source>J Hand Surg Am</source>
            <year>2007</year>
            <season>Jul-Aug</season>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>887</fpage>
            <page-range>887-92</page-range>
            <pub-id pub-id-type="pmid">17606072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Altay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bayrakci</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Erekul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saglik</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.</article-title>
            <source>J Orthop Sci</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>415</fpage>
            <page-range>415-23</page-range>
            <pub-id pub-id-type="pmid">17909925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartz</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wroble</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Millar</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Bonfiglio</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The malignant potential of enchondromatosis.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-74</page-range>
            <pub-id pub-id-type="pmid">3805090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albregts</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Rapini</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Malignancy in Maffucci's syndrome.</article-title>
            <source>Dermatol Clin</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-8</page-range>
            <pub-id pub-id-type="pmid">7712654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21074.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ketcham</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Maffucci's syndrome: functional and neoplastic significance. Case report and review of the literature.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1973</year>
            <month>Oct</month>
            <volume>55</volume>
            <issue>7</issue>
            <fpage>1465</fpage>
            <page-range>1465-79</page-range>
            <pub-id pub-id-type="pmid">4586088</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
